Vidoni et al. [24] showed that lower BMI is associated with biomarkers of cerebral amyloid and tau in cognitively normal and MCI individuals, suggesting a correlation between lower BMI and higher pathophysiology of Alzheimer’s disease in its earliest stages. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.